vs
Side-by-side financial comparison of Ceribell, Inc. (CBLL) and Dominari Holdings Inc. (DOMH). Click either name above to swap in a different company.
Dominari Holdings Inc. is the larger business by last-quarter revenue ($30.1M vs $24.8M, roughly 1.2× Ceribell, Inc.). Ceribell, Inc. runs the higher net margin — -54.6% vs -438.1%, a 383.5% gap on every dollar of revenue.
Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.
CBLL vs DOMH — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $24.8M | $30.1M |
| Net Profit | $-13.5M | $-131.8M |
| Gross Margin | 87.3% | — |
| Operating Margin | -58.9% | -8.9% |
| Net Margin | -54.6% | -438.1% |
| Revenue YoY | — | 220.4% |
| Net Profit YoY | — | -12426.2% |
| EPS (diluted) | $-0.35 | $-6.94 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $24.8M | $30.1M | ||
| Q3 25 | $22.6M | $50.8M | ||
| Q2 25 | $21.2M | $34.1M | ||
| Q1 25 | $20.5M | $8.1M | ||
| Q4 24 | — | $9.4M | ||
| Q3 24 | $17.2M | $4.0M | ||
| Q2 24 | — | $6.2M | ||
| Q1 24 | — | $1.4M |
| Q4 25 | $-13.5M | $-131.8M | ||
| Q3 25 | $-13.5M | $125.2M | ||
| Q2 25 | $-13.6M | $16.6M | ||
| Q1 25 | $-12.8M | $-32.5M | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | $-10.4M | $-4.2M | ||
| Q2 24 | — | $-6.1M | ||
| Q1 24 | — | $-5.4M |
| Q4 25 | 87.3% | — | ||
| Q3 25 | 88.3% | — | ||
| Q2 25 | 88.1% | — | ||
| Q1 25 | 87.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 87.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -58.9% | -8.9% | ||
| Q3 25 | -64.8% | -3.1% | ||
| Q2 25 | -70.5% | -57.0% | ||
| Q1 25 | -69.3% | -394.6% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | -57.8% | -79.1% | ||
| Q2 24 | — | -44.3% | ||
| Q1 24 | — | -205.2% |
| Q4 25 | -54.6% | -438.1% | ||
| Q3 25 | -59.6% | 246.4% | ||
| Q2 25 | -64.4% | 48.7% | ||
| Q1 25 | -62.4% | -400.5% | ||
| Q4 24 | — | 11.4% | ||
| Q3 24 | -60.6% | -104.2% | ||
| Q2 24 | — | -99.1% | ||
| Q1 24 | — | -398.0% |
| Q4 25 | $-0.35 | $-6.94 | ||
| Q3 25 | $-0.37 | $7.27 | ||
| Q2 25 | $-0.38 | $1.12 | ||
| Q1 25 | $-0.36 | $-3.02 | ||
| Q4 24 | — | $0.21 | ||
| Q3 24 | $-1.85 | $-0.67 | ||
| Q2 24 | — | $-1.01 | ||
| Q1 24 | — | $-0.91 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $159.3M | $80.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $155.3M | $69.4M |
| Total Assets | $195.8M | $112.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $159.3M | $80.5M | ||
| Q3 25 | $168.5M | $176.2M | ||
| Q2 25 | $177.4M | $28.2M | ||
| Q1 25 | $182.7M | $18.9M | ||
| Q4 24 | — | $8.2M | ||
| Q3 24 | $14.1M | $7.2M | ||
| Q2 24 | — | $12.1M | ||
| Q1 24 | — | $7.1M |
| Q4 25 | $155.3M | $69.4M | ||
| Q3 25 | $164.1M | $210.2M | ||
| Q2 25 | $172.2M | $88.6M | ||
| Q1 25 | $180.9M | $42.4M | ||
| Q4 24 | — | $39.9M | ||
| Q3 24 | $-136.0M | $38.3M | ||
| Q2 24 | — | $42.4M | ||
| Q1 24 | — | $47.7M |
| Q4 25 | $195.8M | $112.9M | ||
| Q3 25 | $199.5M | $223.4M | ||
| Q2 25 | $207.7M | $109.3M | ||
| Q1 25 | $213.5M | $52.3M | ||
| Q4 24 | — | $47.1M | ||
| Q3 24 | $47.1M | $43.4M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $52.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.8M | $22.7M |
| Free Cash FlowOCF − Capex | $-11.0M | — |
| FCF MarginFCF / Revenue | -44.2% | — |
| Capex IntensityCapex / Revenue | 0.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-41.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-10.8M | $22.7M | ||
| Q3 25 | $-11.1M | $-4.9M | ||
| Q2 25 | $-7.5M | $-353.0K | ||
| Q1 25 | $-11.4M | $1.2M | ||
| Q4 24 | — | $-16.7M | ||
| Q3 24 | — | $-4.7M | ||
| Q2 24 | — | $1.4M | ||
| Q1 24 | — | $-8.6M |
| Q4 25 | $-11.0M | — | ||
| Q3 25 | $-11.5M | — | ||
| Q2 25 | $-7.6M | — | ||
| Q1 25 | $-11.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -44.2% | — | ||
| Q3 25 | -50.8% | — | ||
| Q2 25 | -35.9% | — | ||
| Q1 25 | -56.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.7% | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -0.04× | ||
| Q2 25 | — | -0.02× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -15.65× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
